A detailed history of North Star Investment Management Corp. transactions in Haemonetics Corp stock. As of the latest transaction made, North Star Investment Management Corp. holds 4,675 shares of HAE stock, worth $404,527. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,675
Previous 4,675 -0.0%
Holding current value
$404,527
Previous $386,000 2.85%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$82.56 - $93.49 $389,270 - $440,805
-4,715 Reduced 50.21%
4,675 $418,000
Q4 2022

Jan 11, 2023

BUY
$73.85 - $86.14 $693,451 - $808,854
9,390 New
9,390 $0

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.44B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.